In this work, AKT was significantly activated after phycocyanin treatment in T2DM mice and insulin-resistant SMMC-7721 cell models, which provided the underlying mechanism of phycocyanin in the process of ameliorating diabetes. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.